Q1 FY27 results: PAT jumps 5x to Rs 3.75 Cr; AGM on Sep 30

Management Changes View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+5.6%Reaction day

₹220.10

prior close

₹220.90

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.1%+5.5% vs market

Edible Oil peers, median of 21sector-0.5%+6.1% vs sector

On the reaction day the stock moved 5.5 pts more than Nifty Microcap 250 and 6.1 pts more than its Edible Oil peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+5.6+0.1+5.5-0.5+6.1

Next day

+8.0+0.5+7.5-0.7+8.7

+14.4-0.1+14.5-1.6+16.1

+28.1+0.4+27.7-1.4+29.5

+18.6+0.7+17.9-1.8+20.4

+17.7+0.9+16.7-0.6+18.2

+9.2+1.1+8.1-1.5+10.7

15d

+6.8+1.6+5.2-2.2+9.0

+2.6-0.7+3.3-4.8+7.4

—-3.2—-6.5—

—————

UpDownMarket · Nifty Microcap 250Sector · Edible Oil peers, median of 21Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Ambar Protein Industries board met on Aug 14, 2026 and approved Q1 FY27 unaudited results. Revenue fell 3% to about Rs 113.45 Cr, but PAT jumped over 5 times to Rs 3.75 Cr versus Rs 0.75 Cr a year ago, with basic EPS at Rs 6.53. The board also approved the 33rd AGM on Sep 30, 2026, related party sale of tin filing machineries to Ankur Oil Industries at arm length price, commission to non-executive directors, and revision in Managing Director and Whole Time Director remuneration, all subject to shareholder approval.

Likely market impact

Strong profit growth signals margin improvement despite lower revenue; related party deals and director pay hike need shareholder nod at AGM.